Ozempic Is About to Go Generic in India, China and Canada

- Novo Nordisk's patent for Ozempic is nearing expiration in India, China, and other countries.
- This development will allow for the introduction of generic, more affordable versions of the drug.
- The move is expected to increase competition and accessibility to the weight loss medication in these markets.